AI Assistant
Blog
Pricing
Log In
Sign Up
Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
